Group One Trading
DMRA

Group One Trading’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Group One Trading’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-796
Closed -$14.3K – 7660
2023
Q3 		$14.3K Hold
796
– – ﹤0.01% 6128
2023
Q2 		$50.1K Buy
+796
New +$43.3K ﹤0.01% 5275

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading's DMRA Position: Q2 2025 in Review

Group One Trading sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2025, closing a stake of 3 shares — an estimated $9 sold.

Group One Trading first reported a position in DMRA in Q2 2024 and held it in 4 quarters. The position peaked at $37 in Q3 2024. 9 funds tracked by Wall St. Rank hold DMRA as of Q2 2025.

  • Group One Trading reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3 Damora Therapeutics, Inc. Ordinary Shares shares in Q2 2025, an estimated $9.
  • Group One Trading first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2024 and held it in 4 quarters.
  • Group One Trading's Damora Therapeutics, Inc. Ordinary Shares position peaked at $37 in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.